What Can You Expect at the Premier Industry Forum for Obesity & Weight Loss Drug Development?
As obesity becomes biopharma's leading R&D opportunity, the race is on to define the next generation of therapies beyond GLP-1s. The 3rd Obesity & Weight Loss Drug Development Summit West brings together pharma and biotech leaders to benchmark strategy, evaluate emerging mechanisms and combination approaches, and navigate the evolving competitive landscape.
Expect industry-led case studies, strategic discussions, and high-value networking focused on improving tolerability, preserving muscle, expanding patient access, and delivering more durable, personalised outcomes that will define the future of obesity therapeutics.
Unmissable Event Highlights
Identify the Breakthrough Mechanisms Defining Life Beyond GLP-1s
Hear from Incregen Therapeutics, Moonwalk Bioscience, Lipidio Pharmaceuticals, KayoThera, Gordian Biotechnology, ClicBio, and Replicate Bioscience as they explore adipose-targeted siRNA, energy expenditure pathways, and novel CNS targets. Understand the science and strategy behind the most differentiated obesity programs competing to shape the next era of weight management.
Unlock Greater Efficacy with Next-Generation Combination Therapies
Learn from Ridgeline Therapeutics, Biomea Fusion, Biolexis Therapeutics, and Protagonist Therapeutics about how leading developers are combining GLP-1s with Triple-G agonists, AMPK activators, and muscle-preserving approaches. Explore strategies designed to improve body composition, enhance durability, and deliver healthier long-term weight loss outcomes.
Improve Patient Retention Through Better Tolerability & Adherence
Gain practical insights from Vivani, Genentech, and Sparrow Pharma on overcoming the barriers limiting real-world treatment success. Discover innovations in dosing, delivery, and patient support that address tolerability challenges, reduce discontinuation rates, and help patients achieve more sustainable outcomes.
Differentiate Your Asset in an Increasingly Competitive Market
Explore perspectives from Immunis on how patient stratification, body composition assessment, and muscle function metrics are redefining obesity treatment. Learn how developers can position therapies beyond weight loss alone and demonstrate meaningful clinical and commercial value.
Explore the Full Event Guide
- Hear from 80% + Speakers at VP+ Level
- Join 10+ Companies Unveiling New Data
- Learn from 14+ New Speaking Companies
- 90%+ New Biopharma Speaking Individuals with new Case Studies
- Free* Attendance for Representatives from Biopharma
Attending Companies Include
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of obesity drug development and make critical connections during our dedicated networking sessions.